| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/18/2002 | WO2002013758A3 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 07/18/2002 | WO2002006316A3 Alpha-msh related compounds and methods of use |
| 07/18/2002 | WO2002004522A3 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 07/18/2002 | WO2002002789A3 Compositions and methods for producing recombinant virions |
| 07/18/2002 | WO2001094551A3 Genetically modified t-cells, method for producing them and use thereof |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001088134A3 Novel human lipocalin homologs and polynucleotides encoding the same |
| 07/18/2002 | WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 07/18/2002 | WO2001084565A3 Method and apparatus for manufacture of magnetizable microparticles |
| 07/18/2002 | WO2001083749A3 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 07/18/2002 | WO2001083503A3 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 07/18/2002 | WO2001081590A3 Protein phosphatases |
| 07/18/2002 | WO2001081544A3 Identification and uses of a hyaluronan receptor |
| 07/18/2002 | WO2001081408A3 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 07/18/2002 | WO2001079282A3 Molecules associated with human reproduction |
| 07/18/2002 | WO2001079273A3 Viruses comprising mutated ion channel protein |
| 07/18/2002 | WO2001078789A3 Poliovirus replicons encoding therapeutic agents and uses thereof |
| 07/18/2002 | WO2001072822A3 Genes involved in intestinal inflammatory diseases and use thereof |
| 07/18/2002 | WO2001068705A3 Il-17 receptor like molecules and uses thereof |
| 07/18/2002 | WO2001062920A3 Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| 07/18/2002 | WO2001060400B1 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 07/18/2002 | WO2001058461A9 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 07/18/2002 | WO2001055309A3 Nucleic acids, proteins, and antibodies |
| 07/18/2002 | WO2001055304A3 Nucleic acids, proteins, and antibodies |
| 07/18/2002 | WO2001005834A9 Human tumor necrosis factor receptors tr13 and tr14 |
| 07/18/2002 | WO2000078972A9 Regulation with binding cassette transporter protein abc1 |
| 07/18/2002 | US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/18/2002 | US20020094967 Polynucleotide |
| 07/18/2002 | US20020094955 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 07/18/2002 | US20020094954 Nucleic acids comprising the neuregulin-1-associated gene 1 (NRG1AG1) |
| 07/18/2002 | US20020094340 Chlamydia antigens and corresponding dna thereof |
| 07/18/2002 | US20020094326 Treating tissue with phosphodiesterase inhibitor compound and administering exogenous nucleic acid |
| 07/18/2002 | US20020094324 Gene therapy for restenosis using an adenoviral vector |
| 07/18/2002 | US20020092539 Hair clip |
| 07/18/2002 | DE10100280A1 DNA-Sequenzen, codierend für ein Apoptose-Signaltransduktionsprotein DNA sequences encoding an apoptosis-Signaltransduktionsprotein |
| 07/18/2002 | DE10059631A1 T-Zellepitope des Papillomavirus L1-und E7-Proteins und ihre Verwendung in Diagnostik und Therapie T cell epitopes of the papillomavirus L1 and E7 protein and their use in diagnostics and therapy |
| 07/18/2002 | CA2436876A1 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | CA2434567A1 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/18/2002 | CA2434543A1 Inhibition of pathological angiogenesis in vivo |
| 07/18/2002 | CA2434431A1 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway |
| 07/18/2002 | CA2434402A1 Modular transfection systems |
| 07/18/2002 | CA2433451A1 Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes |
| 07/18/2002 | CA2433449A1 Metabolic gene polynucleotides and polypeptides and uses thereof |
| 07/18/2002 | CA2432350A1 Method for inhibiting the expression of a target gene |
| 07/18/2002 | CA2432341A1 Method for inhibiting the expression of a target gene and medicament for treating a tumor disease |
| 07/18/2002 | CA2430794A1 Human genes and gene expression products isolated from human prostate |
| 07/18/2002 | CA2428497A1 Targeted modification of intracellular compounds |
| 07/17/2002 | EP1223221A2 Recombinant vector for use in gene therapy for insulindependent diabetes mellitus and therapeutic composition thereof |
| 07/17/2002 | EP1223173A2 Novel 2'-O-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof |
| 07/17/2002 | EP1222933A1 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the Wnt-pathway |
| 07/17/2002 | EP1222466A2 Method to identify compounds which modulate fra-1 expression fils |
| 07/17/2002 | EP1222313A2 Genes associated with obesity and methods for using the same |
| 07/17/2002 | EP1222300A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 07/17/2002 | EP1222299A1 Production of recombinant aav using adenovirus comprising aav rep/cap genes |
| 07/17/2002 | EP1222289A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 07/17/2002 | EP1222286A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 07/17/2002 | EP1222284A2 22196, a novel human aminopeptidase |
| 07/17/2002 | EP1222280A2 Apoptosis inducing proteinaceous substance |
| 07/17/2002 | EP1222279A2 Growth factor polypeptides and nucleic acids encoding same |
| 07/17/2002 | EP1222278A1 Oculomedin and glaucoma |
| 07/17/2002 | EP1222277A2 Endozepine-like polypeptides and polynucleotides encoding same |
| 07/17/2002 | EP1222276A2 Polynucleotides and polypeptides encoded thereby |
| 07/17/2002 | EP1222274A2 Mage-a12 antigenic peptides and uses thereof |
| 07/17/2002 | EP1222273A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 07/17/2002 | EP1222272A2 Polypeptides and polynucleotides encoding same |
| 07/17/2002 | EP1222270A2 Proteins and polynucleotides encoded thereby |
| 07/17/2002 | EP1222266A2 Pca3 messenger rna species in benign and malignant prostate tissues |
| 07/17/2002 | EP1222264A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 07/17/2002 | EP1222259A1 ALTERING GENE EXPRESSION WITH ssDNA PRODUCED IN VIVO |
| 07/17/2002 | EP1222255A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 07/17/2002 | EP1222253A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 07/17/2002 | EP1222226A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 07/17/2002 | EP1222211A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 07/17/2002 | EP1222208A1 Polypeptide derivatives of parathyroid hormone (pth) |
| 07/17/2002 | EP1222206A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
| 07/17/2002 | EP1222203A1 Method of altering polypeptide aggregation |
| 07/17/2002 | EP1221961A1 Induction of a strong immune response to a self-tumor associated antigen |
| 07/17/2002 | EP1221955A2 Immunostimulatory nucleic acids |
| 07/17/2002 | EP1221939A1 Ortho ester lipids |
| 07/17/2002 | EP0934082B1 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates |
| 07/17/2002 | CN1359391A 重组腺病毒 Recombinant adenovirus |
| 07/17/2002 | CN1359370A Esters of L-carnitine or alkanoyl L-carnitines |
| 07/17/2002 | CN1359301A Prevention and treatment of amyloidogenic disease |
| 07/17/2002 | CN1359297A Method for preventing tumoral growth |
| 07/17/2002 | CN1358543A Recombination plasmid and application in disease prevention and control |
| 07/16/2002 | US6420551 Antisense oligonucleotides targeted against human immunodeficiency virus |
| 07/16/2002 | US6420546 Oligoribonucleotide and ribozyme analogs with terminal 3′—3′ and/or 5′—5′ linkages |
| 07/16/2002 | US6420545 Nucleotide sequences coding polypeptide for use in the treatment of preferential viral diseases |
| 07/16/2002 | US6420543 Nucleotide sequences coding preferential polypeptide for use in the treatment of immunological and cell proliferative defects |
| 07/16/2002 | US6420532 Binding to human y2 receptors and expression |
| 07/16/2002 | US6420345 Methods and reagents for inhibiting angiogenesis |
| 07/16/2002 | US6420338 Hepatitis b virus (hbv); hepatocellular carcinoma |
| 07/16/2002 | US6420336 Purified antiviral protein, peptide or conjugate encoded by amino acid sequence 90% homologous to seq id no: 2; prophy-lactic or therapeutic inhibition of growth of a virus, such as a retrovirus; human immunodeficiency virus, hiv-1 or hiv-2 |
| 07/16/2002 | US6420335 Cancer therapy; angiostatin or endostatin to sensitize tumor endothelial cells to ionizing radiation |
| 07/16/2002 | US6420176 Composition for delivering DNA into antigen presenting cells |
| 07/16/2002 | US6420170 Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin |
| 07/16/2002 | US6420161 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides |
| 07/16/2002 | US6420160 Expression vector for use in immunotherapy and gene therapy |
| 07/16/2002 | US6420155 Polypeptide for use in the treatment of cancer and atherosclerosis |
| 07/16/2002 | US6420137 Nucleotide sequences coding membrane protein for use treating diet defects and eating disorders |